000 01183 a2200325 4500
005 20250513104949.0
264 0 _c19970220
008 199702s 0 0 eng d
022 _a1062-4821
024 7 _a10.1097/00041552-199609000-00012
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aJose, P A
245 0 0 _aWhat we can learn from the selective manipulation of dopaminergic receptors about the pathogenesis and treatment of hypertension?
_h[electronic resource]
260 _bCurrent opinion in nephrology and hypertension
_cSep 1996
300 _a447-51 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAngiotensin II
_xphysiology
650 0 4 _aAnimals
650 0 4 _aHumans
650 0 4 _aHypertension
_xdrug therapy
650 0 4 _aKidney
_xmetabolism
650 0 4 _aMice
650 0 4 _aRats
650 0 4 _aRats, Inbred SHR
650 0 4 _aRats, Inbred WKY
650 0 4 _aReceptors, Dopamine
_xclassification
700 1 _aFelder, R A
773 0 _tCurrent opinion in nephrology and hypertension
_gvol. 5
_gno. 5
_gp. 447-51
856 4 0 _uhttps://doi.org/10.1097/00041552-199609000-00012
_zAvailable from publisher's website
999 _c8930218
_d8930218